TTRX TTRX
Company Profile ↓Company Overview
TTRX (TTRX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +34.71% |
| 6 Months: | +139.34% |
| 3 Months: | +154.86% |
| 1 Month: | -2.88% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)59.94 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | - | 0 | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | 1.37M | - | - |
| Operating Income | -672.99K | - | -1.37M | - | - |
| EBITDA | - | - | -1.37M | - | - |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | - | -1.24M | - | - |
| Tax Provision | - | - | - | - | - |
| Net Income | -666.44K | - | -1.24M | - | - |
| Diluted EPS | -0.03 | -0.01 | -0.04 | -0.06 | -0.03 |
| R&D Expense | 153.28K | 9.26K | - | 158.70K | 109.43K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 2.31M | 1.80M | - |
| Operating Income | -2.31M | -1.80M | - |
| EBITDA | -2.26M | -1.75M | - |
| Interest Expense | - | - | - |
| Pretax Income | -2.29M | -1.77M | - |
| Tax Provision | - | - | - |
| Net Income | -2.29M | -1.77M | - |
| Diluted EPS | -0.08 | -0.06 | -0.12 |
| R&D Expense | - | 245.96K | 265.57K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | 2.01M | 2.05M | 12.16M |
| Current Assets | 1.20M | 1.10M | - |
| Cash & Equivalents | 1.18M | 872.60K | 4.03M |
| Inventory | - | - | - |
| Receivables | - | - | - |
| Total Liabilities | 1.93M | 2.23M | 7.48M |
| Current Liabilities | 489.78K | 707.93K | 6.00M |
| Long Term Debt | - | - | - |
| Total Debt | 25.16K | 121.04K | - |
| Total Equity | 85.77K | -177.43K | 4.69M |
| Shares Outstanding | - | - | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -1.38M | -1.36M | -2.56M |
| Investing Cash Flow | -44.31K | -99.47K | -152.99K |
| Financing Cash Flow | 500.00K | 1.15M | 6.92M |
| Capital Expenditure | -44.31K | -99.47K | - |
| Free Cash Flow | -1.42M | -1.46M | - |
| Net Change in Cash | -921.99K | -308.40K | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | - | - | - |
| Net Margin % | - | - | - |
| ROE % | -2,672.6% | 996.7% | - |
| ROCE % | -151.5% | -134.0% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TTRX
TTRX Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9UbjlfZzdQeG5kQWNLRmZLZjZwYkp6dmRHcXF3LWp5RWtFR1FKU2RvdUhVSDRLVktOLUE3SllKeFlERDVFVmQxUl9WOTJqcU9WRlhhWTk3UmpDSS1zQm1xUzE0Um9xLXFxcktLQmJJQ0p4RU1QZjVLYUpR?oc=5" target="_blank">TTR…
GX-03 trial data and cash runway at Turn Therapeutics (NASDAQ: TTRX) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNWGI1cnVlQzVRVllIc1AxbkU2RUIweFRuTW1QaXE3NXd0VkpmYy1Sak5rNldFMmE2Sy1UVFZfdmhSUDdaemZpQllfQk1BdWdieVpmd1NzekNJZ2hJc3RXeTRUUFZEQXRob1MyNDJibmVPby11cmx4ODhYUlRBSEZ5bDhEc21VeUxTbVhTc2…
Zacks Research Upgrades Turn Therapeutics (NASDAQ:TTRX) to Hold - MarketBeat
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPVTdvRnZ2NXFHaEkxT282OVdnZ2pTdTg5eWkyVVdvV0kyZkVtZk9sQ1R3MFlUR3pUYmc4RGQxNUxnZHowZ2xfNlUyQkpyVjR1MDNCLUNtbW9BLU5zZ09MNEhRSm44RUhDRWoxUk1ubWlOX2ZYcndPQmJLTGMtQk5HUUtvN0luWjVJT1JuTU…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE55aUZST196WV80Zjd1enQxcXFjbkVMMjE1RlFyaUZhdTN5TUJEWndLOTF4MU9BWndxX2VkbXJrTWFTUXd4X21nSHVsQlAyZlAw?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Turn Therapeutics stock rises on expanded dermatitis trial By Investing.com - Investing.com Nigeria
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNYm1aTVhXbllUVmF4Yk1FVERrVmVVNUVOSTJibUdhakVfY3JVcHQxSFp1THk5LXQyR2M1RzNjV3c5WVRvRy1HUU5tNko5aWM4d09Pd1BPSEwzOVV3aWlfMmtpVUl5THJrYVNycUFYLUhHS2txTG45aS1lOUFBRTNiQXRrWGpFZkN4SnZDcX…
Turn Therapeutics: Small Market Cap, Huge Potential (NASDAQ:TTRX) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOOUkzTVFuaktDMkdSdnJtX2F1WlFBakh5Y3dtQk4xQVhXUkFWdkFGTW5qWHRZeE1SY2xuSXhjRGdaNWtiamhQRFBjMjhXVzMxMlFid1F3TTZxblc1UGI0RTlGdGY2NzJnYnpUek5GNEtCMHA2S0RtRzVLdEFmc2lOa0lxWTdxU0ZiZnVhZD…
TTRX — Frequently Asked Questions
What is the current share price of TTRX?
As of 2026-08-05 17:25 PDT, TTRX trades at $9.43 on NASDAQ/NYSE. Its 52-week range is $2.71 to $10.18.
What is the P/E ratio of TTRX?
TTRX trades at a trailing price-to-earnings (P/E) ratio of -78.58.
What is the return on equity (ROE) of TTRX?
TTRX has a return on equity (ROE) of -37.73%. Its return on capital employed (ROCE) is -29.18%.
Is TTRX a good stock to buy?
This page provides a data-driven analysis of TTRX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.